ANTIMONOVA et al.
600
(2H, 12′-H, J = 5.4), 3.15 d (1H, 28-H, J = 9.0), 3.57 d
(1H, 28-H, J = 8.8), 3.70 t (2H, 13′-H, J = 5.5), 4.45 m
(1H, 3-H), 4.56 br.s and 4.66 br.s (1H each, 29-H),
7.39–7.47 m (2H, Harom), 7.51–7.58 m (1H, Harom),
7.99–8.05 m (2H, Harom). 13C NMR spectrum, δC, ppm:
14.74 q (C27), 15.99 q (C26), 16.13 q (C25), 16.45 q
(C24), 18.12 t (C6), 19.06 q (C30), 20.78 t (C11), 21.30 q
(C32), 23.65 t (C2), 25.09 t (C12), 27.10 t (C15), 27.90 q
(C23), 29.77 t (C16), 30.11 t (C21), 31.00 t (C12′), 34.09 t
(C7), 34.83 t (C22), 37.03 s (C10), 37.49 d (C13), 37.76 s
(C4), 38.34 t (C1), 40.88 s (C8), 42.65 s (C14), 47.11 s
(C17), 47.87 d (C19), 48.70 d (C18), 50.24 d (C9),
55.33 d (C5), 65.82 s (C5′), 69.33 t (C13′), 69.75 s (C28),
80.87 d (C3), 109.82 t (C29), 128.42 d (Cm), 129.38 d
(Co), 132.86 d (Cp), 150.20 s (C20), 159.05 s (Ci),
164.08 s (C3′), 171.01 s (C31). Mass spectrum: m/z
656.4654 [M]+. C42H60N2O4. Calculated: M 6561.4638.
fluoroacetic anhydride, 0.018 ml (0.13 mmol), was
added under argon to a solution of 0.073 g
(0.13 mmol) of compound XVIII in 3 ml of methylene
chloride. The mixture was kept for 24 h at room
temperature, washed with 10% hydrochloric acid and
water, dried over anhydrous MgSO4, and evaporated.
The residue was purified by chromatography on silica
gel using chloroform as eluent. Yield 0.07 g (85%),
mp 128–131°C. IR spectrum, ν, cm–1: 1735 (C=O),
1
1643 (C=C). H NMR spectrum, δ, ppm (J, Hz):
0.59 m (1H, 5-H), 0.65 s (3H, C24H3), 0.76 s (3H,
C25H3), 0.78 s (3H, C26H3), 0.88 s (3H, C27H3), 0.93 s
(3H, C23H3), 1.55 t (1H, 18-H, J = 11.3), 1.66 (3H,
C30H3), 2.74 d.d (1H, 3-H, J = 4.1), 2.93–3.15 m (3H,
7-H, 19-H) 3.64 s (3H, C31H3), 3.99 m (1H, 8-H),
4.58 br.s and 4.72 br.s (1H each, 29-H). 13C NMR
spectrum, δC, ppm: 14.67 q (C27), 15.94 q (C26),
16.08 q (C25, C24), 18.18 t (C6), 19.37 q (C30), 20.90 t
(C11), 22.89 t (C2), 25.53 t (C12), 27.34 q (CF3), 27.73 q
(C23), 29.66 t (C15), 30.61 t (C21), 32.17 t (C16), 27.26 t
(C7′) 34.30 t (C7), 36.97 t (C22), 37.13 s (C10), 38.25 d
(C13), 38.49 s (C1), 38.76 t (C4), 40.70 s (C8), 42.38 s
(C14), 46.97 d (C19), 49.48 d (C18), 50.53 d (C9),
51.24 q (C31), 55.75 d (C5), 56.55 s (C17), 65.49 t (C8′),
65.49 s (C5′), 87.46 d (C3), 109.55 t (C29), 150.60 s
(C20), 169.76 s (C3′), 176.63 s (C28). 19F NMR spec-
trum: δF 96.25 ppm (3F, CF3). Mass spectrum:
m/z 634.3954 [M]+. C36H53F3N2O4. Calculated:
M 634.3952.
Methyl 3β-[3-amino-3-(hydroxyimino)propoxy]-
lup-20(29)-en-28-oate (XXVII). A solution of 0.093 g
(2.81 mmol) of hydroxylamine in 10 ml of butan-1-ol
was added to 0.49 g (0.94 mmol) of compound XVIII,
the mixture was heated for 10 h at 60°C and poured
into a mixture of ice with hydrochloric acid, and the
precipitate was filtered off, washed with water until
neutral washings, and dried in air. The product was
isolated by preparative thin-layer chromatography on
silica gel using chloroform–methanol (20:1) as eluent.
Yield 0.28 g (53%), mp 191–194°C. IR spectrum, ν,
cm–1: 1716 (C=O), 1665 (C=N), 1642 (C=C). 1H NMR
spectrum (only characteristic signals are given), δ, ppm
(J, Hz): 0.64 (1H, 5-H), 0.72 s (3H, C24H3), 0.79 s (3H,
C25H3), 0.88 s (3H, C26H3), 0.91 s (3H, C23H3), 0.92 s
(3H, C27H3), 1.55 t (1H, 18-H, J = 11.3), 1.65 s (3H,
C30H3), 1.81–1.92 m (2H, 21-H, 22-H), 2.10–2.24 m
(2H, 13-H, 16-H), 2.35 m (2H, 32-H), 2.74 d.d (1H,
3-H, J = 4.1), 2.96 t.d (1H, 19-H, J = 4.5, 10.8), 3.45 m
(1H, 31-H), 3.64 s (3H, C30H3), 3.77 m (1H, 31-H),
4.57 br.s and 4.71 br.s (1H each, 29-H), 5.04 br.s (2H,
NH2). 13C NMR spectrum, δC, ppm: 14.23 q (C27),
15.50 q (C26), 15.61 q (C25), 15.93 q (C24), 17.77 t (C6),
18.93 q (C30), 20.45 t (C11), 22.36 t (C2), 25.06 t (C12),
27.75 q (C23), 29.20 t (C32), 30.15 t (C15), 31.19 t (C21),
31.72 t (C16), 33.85 t (C7), 36.51 t (C22), 36.68 s (C10),
37.80 d (C13), 38.04 t (C1), 38.26 s (C4), 40.24 s (C8),
41.92 s (C14), 46.51 d (C19), 49.02 d (C18), 50.07 d
(C9), 50.82 q (C34), 55.30 d (C5), 56.10 s (C17), 66.98 t
(C31), 87.03 d (C3), 109.13 t (C29), 150.12 s (C20),
154.06 s (C33), 176.21 s (C28). Mass spectrum: m/z
556.4274 [M]+. C34H56N2O4. Calculated: M 556.4264.
This study was performed under financial support
by the Russian Foundation for Basic Research (project
no. 09-03-00183).
REFERENCES
1. Mironov, M.E., Kharitonov, Yu.V., Shul’ts, E.E., Shaki-
rov, M.M., Gatilov, Yu.V., and Tolstikov, G.A., Russ. J.
Org. Chem., 2010, vol. 46, p. 1869.
2. Krasutsky, P.A., Nat. Prod. Rep., 2006, vol. 23, p. 919;
Dzubak, P., Hajduch, M., Vydra, D., Hustova, A.,
Kvasnica, M., Biedermann, D., Markova, L., Urban, M.,
and Sarek, J., Nat. Prod. Rep., 2006, vol. 23, p. 394;
Saxena, B.B., Zhu, L., Hao, M., Kisilis, E., Katdare, M.,
Oktem, O., Bomshteyn, A., and Rathnam, P., Bioorg.
Med. Chem., 2006, vol. 14, p. 6349; Santos, R.S., Salva-
dor, J.A.R., Marin, S., and Cascante, M., Bioorg. Med.
Chem., 2009, vol. 17, p. 6241; Kuo, R.-Y., Qian, K.,
Morris-Natschke, S.L., and Lee, K.-H., Nat. Prod. Rep.,
2009, vol. 26, p. 1321.
3. Shintyapina, A.B., Shul’ts, E.E., Petrenko, N.I., Uzenko-
va, N.V., Tolstikov, G.A., Pronkina, N.V., Kozhevni-
kov, V.S., and Pokrovskii, A.G., Bioorg. Khim., 2007,
vol. 33, p. 624; Antimonova, A.N., Uzenkova, N.V.,
Methyl 3β-[2-(5-trifluoromethyl-1,2,4-oxadiazol-
3-yl)ethoxy]lup-20(29)-en-28-oate (XXVIII). Tri-
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 47 No. 4 2011